Literature DB >> 22239910

Outbreaks of human monkeypox after cessation of smallpox vaccination.

Mary G Reynolds1, Inger K Damon.   

Abstract

The recent observation of a surge in human monkeypox in the Democratic Republic of the Congo (DRC) prompts the question of whether cessation of smallpox vaccination is driving the phenomenon, and if so, why is re-emergence not universal throughout the historic geographic range of the virus? Research addressing the virus's mechanisms for immune evasion and induction, as well as that directed at elucidating the genes involved in pathogenesis in different viral lineages (West African vs Congo Basin), provide insights to help explain why emergence appears to be geographically limited. Novel vaccines offer one solution to curtail the spread of this disease. Published by Elsevier Ltd.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22239910     DOI： 10.1016/j.tim.2011.12.001

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  52 in total

1.  Human Monkeypox in the Kivus, a Conflict Region of the Democratic Republic of the Congo.

Authors:  Andrea M McCollum; Yoshinori Nakazawa; Guy Mutombo Ndongala; Elisabeth Pukuta; Stomy Karhemere; Robert Shongo Lushima; Benoit Kebela Ilunga; Joelle Kabamba; Kimberly Wilkins; Jinxin Gao; Yu Li; Ginny Emerson; Inger K Damon; Darin S Carroll; Mary G Reynolds; Jean Malekani; Jean-Jacques Muyembe Tamfum
Journal:  Am J Trop Med Hyg       Date:  2015-08-17       Impact factor: 2.345

Review 2.  The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data.

Authors:  M Shannon Keckler; Mary G Reynolds; Inger K Damon; Kevin L Karem
Journal:  Vaccine       Date:  2013-08-27       Impact factor: 3.641

3.  Vacated niches, competitive release and the community ecology of pathogen eradication.

Authors:  James O Lloyd-Smith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

4.  KAY-2-41, a novel nucleoside analogue inhibitor of orthopoxviruses in vitro and in vivo.

Authors:  Sophie Duraffour; Robert Drillien; Kazuhiro Haraguchi; Jan Balzarini; Dimitri Topalis; Joost J van den Oord; Graciela Andrei; Robert Snoeck
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

5.  Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques.

Authors:  Graham J Hatch; Victoria A Graham; Kevin R Bewley; Julia A Tree; Mike Dennis; Irene Taylor; Simon G P Funnell; Simon R Bate; Kimberley Steeds; Thomas Tipton; Thomas Bean; Laura Hudson; Deborah J Atkinson; Gemma McLuckie; Melanie Charlwood; Allen D G Roberts; Julia Vipond
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

6.  Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012.

Authors:  Donald F Smee
Journal:  Future Virol       Date:  2013-09       Impact factor: 1.831

7.  Human infection with a zoonotic orthopoxvirus in the country of Georgia.

Authors:  Neil M Vora; Yu Li; Marika Geleishvili; Ginny L Emerson; Ekaterine Khmaladze; Giorgi Maghlakelidze; Archil Navdarashvili; Khatuna Zakhashvili; Maka Kokhreidze; Marina Endeladze; Gela Mokverashvili; P S Satheshkumar; Nadia Gallardo-Romero; Cynthia S Goldsmith; Maureen G Metcalfe; Inger Damon; Edmond F Maes; Mary G Reynolds; Juliette Morgan; Darin S Carroll
Journal:  N Engl J Med       Date:  2015-03-26       Impact factor: 91.245

8.  Comparative live bioluminescence imaging of monkeypox virus dissemination in a wild-derived inbred mouse (Mus musculus castaneus) and outbred African dormouse (Graphiurus kelleni).

Authors:  Patricia L Earl; Jeffrey L Americo; Catherine A Cotter; Bernard Moss
Journal:  Virology       Date:  2014-12-02       Impact factor: 3.616

9.  Evaluation of monkeypox virus infection of black-tailed prairie dogs (Cynomys ludovicianus) using in vivo bioluminescent imaging.

Authors:  Elizabeth A Falendysz; Angela M Londoño-Navas; Carol U Meteyer; Nicola Pussini; Juan G Lopera; Jorge E Osorio; Tonie E Rocke
Journal:  J Wildl Dis       Date:  2014-04-29       Impact factor: 1.535

10.  High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination.

Authors:  Iana H Haralambieva; Ann L Oberg; Neelam Dhiman; Inna G Ovsyannikova; Richard B Kennedy; Diane E Grill; Robert M Jacobson; Gregory A Poland
Journal:  J Infect Dis       Date:  2012-09-04       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.